Originally posted by Xi Wang
View Post
Unconfigured Ad
Collapse
X
-
Alignment score and mapping quality are not the same. The former is a measurement of the distance (or log-odds see:BLOSUM) between the observed sequence and reference sequence while the latter is generally the Phred-scaled probability of mismapping. In the SAM format, the alignment score can be stored in the "AS" tag while the fifth column is the mapping quality.
-
Thank you very much for the reply. I was referring to the 5th column. It IS the mapping quality according to SAM manual. But I guess this mapping quality must be correlated with alignment score for some way.
I have seen a lot of alignment with low mapping quality (0 or 1). For the input of cufflinks, do you usually filter out these low quality mapping reads? what is the cutoff you usually use?
Thanks
Originally posted by Haneko View PostHi there,
That is actually not the score, but the mapping quality (I'm assuming you're referring to column 5 for 255 "score"). For calculation of score, you will have to take the alignment in colorspace (XL:Z) and the number of colorspace mismatches (XU:Z), then use SOLiD's formula.
A score of 10 shouldn't be appearing in the output. The seed of 25bp mapping with at most 2 mismatches will give u the lowest possible score for an alignment to be reported, which in my case is 18.
Comment
-
Hi clariet,
Actually I've never considered this column to be a factor in filtering, so i can't give you a definite answer. But I think it'd be good to filter away those low quality mappings, perhaps someone could give a recommendation on the threshold?
Comment
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
38 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
||
|
Started by SEQadmin2, 10-13-2026, 09:56 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
10-13-2026, 09:56 AM
|
||
|
Started by SEQadmin2, 10-09-2026, 11:14 AM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
10-09-2026, 11:14 AM
|
Comment